期刊
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
卷 1, 期 5, 页码 356-362出版社
ELSEVIER SCIENCE INC
DOI: 10.1053/S1542-3565(03)00180-0
关键词
-
资金
- National Institutes of Health [M01RR00069, DK RO1-DK50979, DK32083, DK32493, T32 AI07365]
- General Clinical Research Center in the National Center for Research Resources
- Autoimmunity Center of Excellence [U19AI46374]
- Diabetes Endocrine Research Center [P3057516]
- Autoimmunity Prevention Center [5U19AI50864]
- Immune Tolerance Network Autoantibody Core Laboratory
Background & Aims: Asymptomatic children at risk for celiac disease (CD) and seropositive for immunoglobulin A anti-TG autoantibodies (TGAA) may lack small intestinal mucosal changes characteristic of CD. We have followed a group of children with serial testing for TGAA. Methods: Subjects were a group of at-risk children comprised of infants expressing HLA-DR3 on newborn screening, those with type 1A diabetes, or a first-degree relative of someone with type 1 diabetes. All children participating in the prospective study for development of CD underwent serial testing for TGAA. Data from clinical evaluation and small intestinal biopsy were compared to the TGAA levels followed over time. Results: In 42 children, serial TGAA determinations while on a glutencontaining diet showed levels fluctuating 10-100-fold over 3-12 months. A TGAA index more than 0.5 had a positive predictive value (PPV) for histologic confirmation of CD of 96% (22/23). A TGAA index above the usual cutoff for positivity (0.05) had a PPV of only 76% (28/37). Conclusions: In children with TGAA seropositivity, the TGAA level varied over time and a higher titer predicted an abnormal biopsy characteristic of CD. A threshold for biopsy for diagnosis of CD could be set higher for screening-identified cases than for clinically identified cases to decrease the frequency of performing normal biopsies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据